WHO's misinformation hinders the implementation of SARS-CoV-2 plasma therapy

Reporter : Li Zhaoxi / Editor : Li Jia, New Tang Dynasty Television

Ref : https://www.ntdtv.com/gb/2020/08/08/a102913838.html

Image : The picture shows frozen plasma at the National Blood Transfusion Center in Mexico City. (Rodrigo Arangua /AFP via Getty Images)

The World Health Organization (WHO) has deliberately concealed the epidemic and frequently created chaos, coupled with decades of false propaganda, has caused a serious shortage of global plasma supply.

According to a report by the American conservative media "National Review" on 7 August, due to the World Health Organization's (referred to as WHO) false propaganda on plasma donation and plasma therapy, the world has been unable to solve the shortage of plasma for decades. The problems have caused huge obstacles to the implementation of plasma therapy used against SARS-CoV-2.

Since the adoption of the World Health Assembly Resolution 28.72 (World Health Assembly Resolution 28.72) in 1975, WHO has opposed compensation for blood and plasma donors, urging its member states to adopt a 100% voluntary and unpaid donation model.

This model is based on the belief that paid donations will attract volunteers with high-risk lifestyles to participate, resulting in reduced blood and plasma safety. However, for the plasma used in plasma therapy, advances in testing and other technologies have made the safety of paid donations not a problem.

Due to the adoption of advanced virus screening, removal, and deactivation technologies, the health authorities of every country have realized that paid plasma donation is as safe and effective as unpaid plasma donation in plasma therapy.

However, the WHO has been disseminating misinformation about the risks of paid plasma to plasma therapy for decades. On the one hand, it actively promotes its member states to pledge to achieve 100% free plasma donation, and on the other hand, it claims that global plasma is in supply shortage.

In 2015, the WHO estimated that approximately 1.4 million people worldwide suffer from primary immunodeficiency (PID), and 75% of them do not have access to appropriate plasma therapy.

More than 70% of the global plasma supply comes from paying US donors. In addition, Germany, Austria, the Czech Republic and Hungary also pay plasma donors. These 5 countries supply 90% of the world's plasma.

The global demand for plasma therapy is growing at a rate of 6% to 10% every year. According to estimates by the Dutch national blood operator Sanquin, by 2025, the United States will be responsible for 90% of Europe's plasma demand, and now this proportion is just over 40%.

The pandemic has not only weakened plasma donations in the United States, but SARS-CoV-2 plasma therapy  has put pressure on the already tight global plasma supply. This not only jeopardizes patients in wealthy countries, but also makes most patients in developing countries more unable to afford plasma therapy.

In order to give patients peace of mind about plasma supply and make plasma therapy more affordable, paying plasma donors has become a general trend.